In the BioHarmony Drug Report Database

"Preview" Icon

Histamine dihydrochloride

Ceplene (histamine dihydrochloride) is a small molecule pharmaceutical. Histamine dihydrochloride was first approved as Ceplene on 2008-10-07. It is used to treat allergic rhinitis seasonal and urticaria in the USA. It has been approved in Europe to treat myeloid leukemia acute.

 

Trade Name

 

Ceplene
 

Common Name

 

histamine dihydrochloride
 

ChEMBL ID

 

CHEMBL1533310
 

Indication

 

allergic rhinitis seasonal, myeloid leukemia acute, urticaria
 

Drug Class

 

Image (chem structure or protein)

Histamine dihydrochloride structure rendering